Form 4: Koru Medical Systems Director Robert Cascella Reports Acquisition of 5,545 Shares

Director Robert Cascella reported acquiring 5,545 shares of Koru Medical Systems at $2.71 per share on July 11, 2024, increasing his total holdings to 65,524 shares.

Summary

• On July 11, 2024, Robert Cascella, a director of Koru Medical Systems, Inc., acquired 5,545 shares of common stock.
• The shares were purchased at a price of $2.71 per share.
• Following the transaction, Cascella's total beneficial ownership of Koru Medical Systems common stock is 65,524 shares.
• The transaction was reported on a Form 4 filing with the SEC.
• Cascella has granted power of attorney to Linda Tharby and Thomas Adams to execute and file Forms 3, 4, and 5 on his behalf.

Sentiment

Score: 5

Explanation: The document is a neutral regulatory filing. The sentiment is neither positive nor negative.

Positives

• A director's purchase of company stock can be seen as a positive signal, indicating confidence in the company's future prospects.

Industry Context

This is a routine disclosure of insider trading activity, which is common for publicly traded companies. It provides transparency into the actions of company insiders.

Stakeholder Impact

• The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company director.

Key Dates